BBWI director buys 22,500 shares at $15.58 weighted average

Bath & Body Works, Inc. director reports open-market share purchase.

Rhea-AI Filing Summary

Bath & Body Works, Inc. director reports open-market share purchase. A company director filed a Form 4 disclosing the purchase of 22,500 shares of Bath & Body Works common stock on 11/24/2025 at a weighted average price of $15.58 per share. After this transaction, the reporting person beneficially owns 40,379 common shares held directly. The filing notes that the purchase price reflects a weighted average, with individual trades executed between $15.575 and $15.58 per share, and that detailed trade-level pricing information will be made available upon request.

Insider Trade Summary

Net Buyer: 22,500 shares

Net Buy 1 txn

Insider Symancyk James Kevin

Role Director

Bought 22,500 shs ($351K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, $0.50 par value	22,500	$15.58	$351K

Holdings After Transaction: Common Stock, $0.50 par value — 40,379 shares (Direct)

Footnotes (1)

1. F1. Price represents a weighted average of the purchase price. Shares were purchased at prices ranging from $15.575 to $15.58. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares purchased at each separate price.

FAQ

What insider transaction did BBWI disclose in this Form 4?

The filing reports that a director purchased 22,500 shares of Bath & Body Works common stock on 11/24/2025 in an open-market transaction.

At what price were the BBWI shares purchased by the director?

The shares were bought at a weighted average price of $15.58 per share, with individual trades executed between $15.575 and $15.58 per share.

How many BBWI shares does the reporting person own after this transaction?

Following the reported purchase, the director beneficially owns 40,379 shares of Bath & Body Works common stock, held directly.

What is the relationship of the reporting person to Bath & Body Works (BBWI)?

The reporting person is identified as a director of Bath & Body Works, Inc., as indicated in the relationship section of the form.

Does this BBWI Form 4 include any derivative securities transactions?

No derivative securities transactions are reported. The table for derivative securities is present but contains no entries for acquisitions or dispositions.

How is the purchase price detail described in the BBWI Form 4?

The filing states that the reported price is a weighted average, and that detailed information on the number of shares purchased at each separate price between $15.575 and $15.58 will be provided upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/25/2025 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Symancyk James Kevin

(Last) (First) (Middle)

THREE LIMITED PARKWAY

(Street)

COLUMBUS OH 43230

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bath & Body Works, Inc. [ BBWI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.50 par value	11/24/2025		P		22,500	A	$15.58(1)	40,379	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Price represents a weighted average of the purchase price. Shares were purchased at prices ranging from $15.575 to $15.58. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares purchased at each separate price.

	Robert J. Tannous, Attorney-in-Fact	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.